Kenneth Maynard

Background

About Kenneth Maynard

A diligent professional with excellent leadership skills, uniquely combining academic and pharmaceutical business, research and development (R&D) experience. Drives strategic, scientific and operational multi-national, cross-functional teams in R&D and external innovation. Identifies external innovation opportunities that complement, diversify and add value to the internal pipeline. Strong academic, pharma, National Institutes of Health, and venture capital network. Previously led a laboratory of medical students and neurosurgeons in research centered on cerebral ischemia and stroke as an Assistant Professor in Surgery (Neurosurgery) at Harvard Medical School and Assistant Neuroscientist in the Neurosurgical Service, at Massachusetts General Hospital. Published 50+ primarily original publications in international, peer-reviewed journals, excluding abstracts. Presently serving on the editorial committees of the American Journal of Pharmacology and Toxicology, Current Neurobiological Research, Current Neurovascular Research and Recent Patent Reviews on CNS Drug Discovery. Recent past leadership roles include Chair, Membership and Communications Committee and held advocacy discussions with 2 members of the US Congress and was a recent participant in the White House Community Leaders Briefing on Cardiovascular Health for the American Heart Association/American Stroke Association’s Stroke Council. Recently served as a member of the Society for Neuroscience’s Finance Committee and currently serve on the Executive Committee of the International Dose-Response Society. Recent invited speaker and panellist covering various topics including, New Models of Innovation, Hormesis and the Pharmaceutical Industry, Winning in the CNS R&D Space and Research Careers in the Private Sector. Specialties: Subject matter expertise in neuroscience, especially cerebrovascular pathophysiology, specifically stroke.